Global Molecular Biology Enzymes and Kits & Reagents Market Overview:
Molecular Biology is the field of biology that studies the composition, structure, and interactions of cellular molecules such as nucleic acids and proteins that carry out the biological processes essential for the cell's functions and maintenance. Molecular biology plays a vital role in understanding the formations, actions, and regulations of various parts of cells, which can be used to efficiently target new drugs, diagnose disease, and understand the cell's physiology. Molecular biology enzymes and kits & reagents are widely used for research, drug discovery, and diagnostic testing.
Global Molecular Biology Enzymes and Kits & Reagents Market Insights
The global molecular biology enzymes and kits & reagents market size was valued at USD 1318.8 million in 2019 and projected to reach USD 4045.8 million by 2027, growing at a CAGR of 13.57% forecast period 2020-2027. The major factors are the rise in the prevalence of genetic disorders and infectious diseases. Additionally, the increasing R&D investments in the life science industry and rising research activities will spur the global molecular biology enzymes and kits & reagents industry in the future periods. Furthermore, the growing public-private funding for molecular biology research activities and technological advancement is expected to witness remarkable molecular biology enzymes and kits & reagents' remarkable growth. Moreover, the upsurge in demand for personalized medicine and the rising number of genome projects positively impact the market for molecular biology enzymes and kits &reagents in the healthcare industry.
Furthermore, the rapidly expanding customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing scope of biomedical applications are fueling the demand for molecular biology enzymes and kits & reagents market. The growing adaptation of molecular diagnostics such as epigenetics and polymerase chain reaction (PCR) will bolster global molecular biology enzymes and kits & reagents market share. Additionally, the growing geriatric population and increasing healthcare demands in the developing world propelling the growth of the molecular biology enzymes and kits & reagents market across the globe.
Growth Driver
Single-cell sequencing provides a vital application area in cancer research. Single-cell sequencing technologies are widely used in the research of various tumors and offer great significance for the development of new diagnostic and anti-tumor treatment methods. In addition, Single-cell sequencing technologies are used to detect the genome, transcriptome, and other multi-omics of single cells. Single-cell genome sequencing offers a viable solution for the effective assessment of biomolecules, including RNA, DNA, chromatin, and protein, which has accelerated revenue growth. Isolation of these molecules from a single cell for advanced molecular profiling enables a better understanding of biological diversity. Due to the advantages of large market size, low market concentration, and gradual maturity of diagnostic technology applications, molecular biology enzymes and kits have attracted various enterprises to the layout.
Product Segmental Analysis
Based on the product, the global molecular biology enzymes and kits & reagents market is segregated into kits &reagents and enzymes. The enzyme segment is further segmented into polymerases, ligases, restriction endonucleases, reverse transcriptases, phosphatases, proteases & proteinases, and other enzymes.
The kits & reagents segment is estimated to witness the highest growth over the analysis timeframe due to repetitive purchase of single-use products, rising need for molecular diagnostics, and rising research on drugs in the pharmaceutical industries.
The enzymes will grow significantly due to the increasing use of proteases in diagnosis, high demand for cloning technology in routine laboratory, and rapid customer base expansion.
Application Segmental Analysis
Based on the application, the global molecular biology enzymes and kits & reagents market is classified into polymerase chain reaction, sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications.
The sequencing is expected to be the highest revenue share for molecular biology enzymes and kits & reagents during the forecast period. The segment's growth is primarily attributed to the decreasing cost of sequencing, rising genomic research, and rising use of whole-genome sequencing & personalized genome sequencing.
The PCR will witness a lucrative growth rate in the estimated period due to growing demand for PCR equipment by the majority of end-users and rapid technological advancements.
End-User Segmental Analysis
Based on the end-user, the global molecular biology enzymes and kits & reagents market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end-users.
The hospital &diagnostics centers segment will dominate the global molecular biology enzymes and kits & reagents market by 2027. Due to the surge in the number of hospitals &diagnostic centers using molecular diagnostics technology, economic expansion, and government focus on broader healthcare policies.
The pharmaceuticals and biotechnology companies accounted for the largest share of the molecular biology enzymes and kits & reagents market in 2019 on account of the rising prevalence of infectious diseases, rising R&D expenditure, and increasing use of molecular biology products in the clinical trial setting.
Region Segmental Analysis
By geography, the global molecular biology enzymes and kits & reagents market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is due to raising research funding for genomic research, leading industry players offering innovative products, and increasing healthcare expenditure.
The Asia Pacific will capture a prominent share of the molecular biology enzymes and kits & reagents market by 2027. The increasing prevalence of conditions involving molecular diagnostics is continually improving healthcare infrastructure in the region and mounting health care expenditures in emerging countries such as India and China.
Competitor Analysis
Companies such as Thermo Fisher Scientific Inc., QIAGEN, Illumina Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Bio-Rad Laboratories Inc., New England Biolabs, Merck KGaA, Promega Corporation, Takara Bio Inc., LGC Limited, Bio Basic, Jena Bioscience, and Molecular Biology Resources are the key players in the global molecular biology enzymes and kits & reagents market.
Key Stakeholders
Market research and consulting firms
Industry associations
Global molecular biology enzymes and kits & reagents manufacturing firm
Research organizations and consulting companies
Organizations, associations, and alliances related to molecular biology enzymes and kits & reagents
Regulatory bodies
Suppliers
Retailers
The objective of the Research
Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy's inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product
Kits & Reagents
Enzymes
By Application
PCR
Sequencing
Cloning
Epigenetics
Restriction Digestion
Synthetic Biology
Other Applications
By End-User
Pharmaceuticals and Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers
Other End Users
By Region
North America
Europe
Asia Pacific
South America
Middle East & Africa
'
1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
3. Executive Summary
4. Market Insights
4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Technological Landscape
4.3. Competitors & Product Analysis
4.4. Regulatory Framework
4.5. Company market share analysis, 2019
4.6. Porter’s Five forces analysis
4.7. New Investment Analysis
4.8. PESTEL Analysis
5. Global Molecular Biology Enzymes and Kits & Reagents Market Overview
5.1. Market Size & Forecast,2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Product
5.2.1.1. Kits & Reagents
5.2.1.2. Enzymes
5.2.2. By Applications
5.2.2.1. PCR
5.2.2.2. Sequencing
5.2.2.3. Cloning
5.2.2.4. Epigenetics
5.2.2.5. Restriction Digestion
5.2.2.6. Synthetic Biology
5.2.2.7. Other Applications
5.2.3. By End-User
5.2.3.1. Pharmaceuticals and Biotechnology Companies
5.2.3.2. Academic & Research Institutes
5.2.3.3. Hospitals & Diagnostic Centers
5.2.3.4. Other End Users
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia Pacific
5.2.4.4. South America
5.2.4.5. Middle East & Africa
6. North America Molecular Biology Enzymes and Kits & Reagents Market Overview
6.1. North America Molecular Biology Enzymes and Kits & Reagents Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. North America Molecular Biology Enzymes and Kits & Reagents Market Share & Forecast,2016-2027
6.2.1. By Product
6.2.1.1. Kits & Reagents
6.2.1.2. Enzymes
6.2.2. By Applications
6.2.2.1. PCR
6.2.2.2. Sequencing
6.2.2.3. Cloning
6.2.2.4. Epigenetics
6.2.2.5. Restriction Digestion
6.2.2.6. Synthetic Biology
6.2.2.7. Other Applications
6.2.3. By End-User
6.2.3.1. Pharmaceuticals and Biotechnology Companies
6.2.3.2. Academic & Research Institutes
6.2.3.3. Hospitals & Diagnostic Centers
6.2.3.4. Other End Users
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
6.2.4.3. Mexico
7. Europe Molecular Biology Enzymes and Kits & Reagents Market Overview
7.1. Europe Molecular Biology Enzymes and Kits & Reagents Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. Europe Molecular Biology Enzymes and Kits & Reagents Market Share & Forecast,2016-2027
7.2.1. By Product
7.2.1.1. Kits & Reagents
7.2.1.2. Enzymes
7.2.2. By Applications
7.2.2.1. PCR
7.2.2.2. Sequencing
7.2.2.3. Cloning
7.2.2.4. Epigenetics
7.2.2.5. Restriction Digestion
7.2.2.6. Synthetic Biology
7.2.2.7. Other Applications
7.2.3. By End-User
7.2.3.1. Pharmaceuticals and Biotechnology Companies
7.2.3.2. Academic & Research Institutes
7.2.3.3. Hospitals & Diagnostic Centers
7.2.3.4. Other End Users
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Rest of Europe
8. Asia Pacific Molecular Biology Enzymes and Kits & Reagents Market Overview
8.1. Asia Pacific Molecular Biology Enzymes and Kits & Reagents Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Molecular Biology Enzymes and Kits & Reagents Market Share & Forecast, 2016-2027
8.2.1. By Product
8.2.1.1. Kits & Reagents
8.2.1.2. Enzymes
8.2.2. By Applications
8.2.2.1. PCR
8.2.2.2. Sequencing
8.2.2.3. Cloning
8.2.2.4. Epigenetics
8.2.2.5. Restriction Digestion
8.2.2.6. Synthetic Biology
8.2.2.7. Other Applications
8.2.3. By End-User
8.2.3.1. Pharmaceuticals and Biotechnology Companies
8.2.3.2. Academic & Research Institutes
8.2.3.3. Hospitals & Diagnostic Centers
8.2.3.4. Other End Users
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Australia
8.2.4.5. Rest of Asia Pacific
9. South America Molecular Biology Enzymes and Kits & Reagents Market Overview
9.1. South America Molecular Biology Enzymes and Kits & Reagents Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Molecular Biology Enzymes and Kits & Reagents Market Share & Forecast,2016-2027
9.2.1. By Product
9.2.1.1. Kits & Reagents
9.2.1.2. Enzymes
9.2.2. By Applications
9.2.2.1. PCR
9.2.2.2. Sequencing
9.2.2.3. Cloning
9.2.2.4. Epigenetics
9.2.2.5. Restriction Digestion
9.2.2.6. Synthetic Biology
9.2.2.7. Other Applications
9.2.3. By End-User
9.2.3.1. Pharmaceuticals and Biotechnology Companies
9.2.3.2. Academic & Research Institutes
9.2.3.3. Hospitals & Diagnostic Centers
9.2.3.4. Other End Users
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
10. Middle East & Africa Molecular Biology Enzymes and Kits & Reagents Market Overview
10.1. Middle East & Africa Molecular Biology Enzymes and Kits & Reagents Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Molecular Biology Enzymes and Kits & Reagents Market Share & Forecast, 2016-2027
10.2.1. By Product
10.2.1.1. Kits & Reagents
10.2.1.2. Enzymes
10.2.2. By Applications
10.2.2.1. PCR
10.2.2.2. Sequencing
10.2.2.3. Cloning
10.2.2.4. Epigenetics
10.2.2.5. Restriction Digestion
10.2.2.6. Synthetic Biology
10.2.2.7. Other Applications
10.2.3. By End-User
10.2.3.1. Pharmaceuticals and Biotechnology Companies
10.2.3.2. Academic & Research Institutes
10.2.3.3. Hospitals & Diagnostic Centers
10.2.3.4. Other End Users
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Thermo Fisher Scientific Inc.
11.7.2. QIAGEN
11.7.3. Illumina Inc.
11.7.4. F. Hoffmann-La Roche Ltd
11.7.5. Agilent Technologies Inc
11.7.6. Bio-Rad Laboratories Inc.
11.7.7. New England Biolabs
11.7.8. Merck KGaA
11.7.9. Promega Corporation
11.7.10. Takara Bio Inc.
11.7.11. LGC Limited
11.7.12. Bio Basic
11.7.13. Jena Bioscience
11.7.14. Molecular Biology Resources
11.7.15. Others Prominent Players
